# Mechanisms of Hypertension in Women With Polycystic Ovary Syndrome

> **NCT04327934** · EARLY_PHASE1 · TERMINATED · sponsor: **Yale University** · enrollment: 28 (actual)

## Conditions studied

- Polycystic Ovary Syndrome
- Hypertension

## Interventions

- **DRUG:** GnRH antagonist
- **DRUG:** GnRH antagonist + MethylTESTOSTERone 5 MG

## Key facts

- **NCT ID:** NCT04327934
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-12-01
- **Primary completion:** 2022-06-30
- **Final completion:** 2022-06-30
- **Target enrollment:** 28 (ACTUAL)
- **Why stopped:** Unble to complete all arms of the planned study due to Covid stoppage and difficulty with recruiting and getting enrolled participants to return post Covid.
- **Last updated:** 2024-02-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04327934

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04327934, "Mechanisms of Hypertension in Women With Polycystic Ovary Syndrome". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04327934. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*